How to Apply for Ethics (Non-CTIMPs) including Sponsorship
|
|
- Austen Greene
- 6 years ago
- Views:
Transcription
1 How to Apply for Ethics (Non-CTIMPs) including Sponsorship Joint Research & Enterprise Office (JREO) St George s University of London Lucy H H Parker Clinical Research Governance Manager Joint Research & Enterprise Office Training 17 th November 2015
2 Outline Background to Ethics Introduction to Ethics in UK Research Ethics Review Process Sponsorship including indemnity After REC HRA UPDATE Joint Research & Enterprise Office Training 17 th November 2015
3 Background : WWII atrocities Nazi Holocaust Unit : Tuskegee Syphilis Study 1947 Nuremburg Code World Medical Association s Declaration of Helsinki
4 : Placebo controlled study of zidovudine to prevent vertical transmission of HIV in Cote d Ivoire, Uganda, Tanzania, South Africa, Malawi onwards: Pfizer in court in Nigeria for Trovan studies during Meningitis epidemic in International Conference of Harmonisation Good Clinical Practice (ICH GCP) EU, Japan and US - Ethical and scientific quality standard Joint Research & Enterprise Office Training th November
5 Introduction Ethical approval: Protects human rights Gives balanced independent view of research Required by regulatory bodies and NHS Prevents scandals in biomedical research Who are the ethics committee? Laymen, clinicians, nurses, pharmacists and other interested parties ICH GCP: An IRB/IEC should safeguard the rights, safety and well being of all trial subjects
6 Research? The attempt to derive generalisable new knowledge If the study involves randomisation it is research MUST come through the JREO for review May require REC review Please see the NRES: Defining Research leaflet: Joint Research & Enterprise Office Training 13 th November 2014
7 Service Evaluation or Clinical Audit? Service Evaluation Designed and conducted solely to define or judge current care Requires Department Lead permission Clinical Audit Designed and conducted to produce information to inform delivery of best care Requires Clinical Audit Manager s review - kate.hutt@stgeorges.nhs.uk
8 UK Ethics National Research Ethics Service (NRES) - core function and directorate of the HRA Dec HRA (Health Research Authority) Special Government Authority Plan for Growth Patients and public Streamline regulation Fundamental remit: Participant safety Facilitate and promote ethical research Joint Research & Enterprise Office Training 13 th November 2014
9 Current REC system National application form Standard operating procedures Single, Independent review Central allocation system Quorate Meetings Simultaneous processing Tight timelines (60 day max) Rejections justified Written clarification once only Approval for amendments Proportionate review Joint Research & Enterprise Office Training 13 th November 2014
10 Is REC review required? Legal requirement: Clinical Trial of an Investigational Medicinal Product (CTIMP) Medical Device if not CE marked or CE marked and used outside clinical indication Involves exposure to ionising radiation additional to routine care Involves intrusive procedures with adults who lack capacity to consent for themselves Joint Research & Enterprise Office Training 13 th November 2014
11 Is REC review required continued Patients and users of the NHS Relatives or carers of patients/users of NHS Access to data/organs/tissue of NHS patients Foetal material and IVF involving NHS patients Recently dead in NHS premises Use of NHS premises/facilities Joint Research & Enterprise Office Training 13 th November 2014
12 Is REC review required continued All relevant material under the Human Tissue Act 2004 Involves storage of relevant material from the living or the deceased on premises without a storage licence from the Human Tissue Authority (HTA) Involves storage or use of relevant material from the living, collected on or after 1 September 2006, and the research is not within the terms of consent for research from the donors Involves analysis of DNA in material from the living, collected on or after 1 September 2006, and the analysis is not within the terms of consent for research from the person whose body manufactured the DNA Joint Research & Enterprise Office Training 13 th November 2014
13 Research Not Requiring REC Review Involving previously collected, non-identifiable information Involving previously collected, non-identifiable tissue samples Involving acellular material Involving NHS staff Please read the guidance carefully and consult the JREO Even if your study does not require REC review, it is likely it will still need R&D approval Does my project require REC review? Joint Research & Enterprise Office Training th November
14 Where to book Proportionate Review Allocation System (PRAS) Studies eligible for proportionate review Central Allocation System (CAS) CTIMP (single or multi site) Non-CTIMP Student Research (non-ctimp) Medical Devices Establishing a Research Tissue Bank Establishing a Research Database CAS to a flagged REC Other Research Phase 1 CTIMPs in healthy volunteers only Directly to an NHS REC with type 1 recognition. Gene therapy or stem cell clinical trials Book to a flagged REC ying-to-recs/nhs-rec-where-to-book/ Adults Lacking capacity Involves Prisoners/Young Offenders Funded by US Department of Health and Human Sciences Joint Research & Enterprise Office Training 13th 17 November
15 CI books in application and given reference number Application PART A&B received DAY 1 Non-valid application returned with feedback and may re-enter system Valid application acknowledged DAY 5 SITE SPECIFIC ASSESSMENT(S) PI at each site applies for SSA via SSIF DAY 1 REC considers application seeking clarification as appropriate Ethical Decision advised Final Decision per site Clock stops DAY 60 (max) Site specific assessment completed DAY 15 (max) Site specific assessments may continue beyond main REC recommendation
16 Proportionate Review No material ethical issues and low burden on participants: Research using data or tissue fully anonymized to the researcher Research using existing tissue samples already taken with consent for research Research using extra tissue (e.g. further blood taken at time of routine sampling or tissue taken at clinically directed operation) Questionnaire research/research interview/focus group (NOT for highly sensitive areas or areas where accidental disclosure would = serious consequences) Research surveying safety/efficacy of established non-drug treatments, involving limited intervention and no change to the patients treatment Minimally invasive basic science studies involving healthy volunteers Turn around time 14 days initial opinion (Favourable or Provisional)
17 IRAS (Integrated Research Application System) Single system for applying for approval for health care research in the UK Enables you to enter the information about your project once instead of duplicating information in separate application forms Filters to ensure that the data collected and collated is appropriate to the type of study Helps you to meet regulatory and governance requirements Joint Research & Enterprise Office Training 13 th November 2014
18 IRAS continued 1. Start a New Project
19 IRAS continued IRAS captures the information needed for the relevant approvals from: Medicines and Healthcare products Regulatory Agency (MHRA) Confidentiality Advisory Group (CAG) ( formerly NIGB or PIAG) Ministry of Justice (National Offender Management Service) Administration of Radioactive Substances Advisory Committee (ARSAC) National Institute for Heath Research (NIHR) Trust approvals (SSAs) **Will also be used to for the HRA process**
20 Sponsorship The sponsor is the individual, or organization (or group of individuals or organizations) that takes on responsibility for confirming there are proper arrangements to initiate, manage and monitor, and finance a study. Research Governance Framework, 2 nd Edition, Department of Health 2005 Non-Commercial studies: Funder Investigator led - Chief Investigator s substantive employer University or the Trust Student Institution where student is studying
21 St George s Sponsorship Submission of Essential Documents to the JREO: Valid Submission: IRAS NHS REC Form (draft, PDF) Supporting Documentation: - Protocol - Participant Information Sheet(s) & Consent Form(s) Additional: - Data Collection Tools - CV s for all key personnel Sponsorship (when Sponsor signs Part D2 of REC form) Evidence of Funding (if applicable) Evidence of Peer Review (if applicable) The JREO will aim to review your valid Sponsorship application within 5 working days
22 REC Essential Documents IRAS REC Form Final Research Protocol Summary CV for CI/PI Patient Information Sheet(s) (PIS) Consent form(s) Signed declaration from CI (D1) Signed declaration from Sponsor (D2) Evidence of insurance or indemnity Remember to version control and date your documents!
23 Good Practice Documents Covering Letter Peer Review - (JREO provides guidance about peer review) GP letter Letter from funder Statistical Analysis Sample diary / patient cards Sample advertisements
24 Ethics: Tricky Questions 1 Project Filter Questions - Q2: Study type consult with JREO if not sure - Q2e (a) If ANY ionising radiation Yes (b/c) If ANY tissue taken Yes - Q9 If any part of study educational - Yes Part A Scientific justification A12 and Scientific Methodology A13 Lay terms Recruitment (A through to A30) how participants will be identified, approached and recruited Advertisements (A28) Submit every advertisement format that you plan to use e.g. posters, plasma screen adverts as well as s
25 Ethics: Tricky Questions 2 Advocacy (A33-1) Provide evidence that arrangements are in place to ensure inclusion in your research of those who are not fluent in English Monitoring arrangements Please consult the JREO (proportionate to risk of study) Main ethical considerations (A6-1 & A6-2) Sponsor Representative (A4) - - use your assigned Research Governance Officer details
26 Ethics: Tricky Questions 3 Part B Ionising Radiation, Radioactive Materials and Human Tissue - Please contact: Radiation Protection Officer Designated Individuals Local Pathology (if above routine) Part C Research Sites - Site (NHS or non-nhs) where any research procedure being conducted - Require Host Site Approval (or NHS Permission) - Applications submitted to R&D departments (SSA) - Local authorisations required
27 Sponsorship and Indemnity Employing organisation should act as sponsor (A64-1) - Chief Investigator s substantive employer Research Governance Officer s details (A68) Indemnity/Insurance assessment required Approval is project specific and must be sought from the Sponsor The NHS site applies its own indemnity for clinically negligent acts University indemnity provides both negligent and non-negligent harm
28 Indemnity For SGUL sponsored studies: Management of the research (A76-1) Tick other and state that SGUL indemnity applies Design of the research (A76-2) Tick other and state that SGUL indemnity applies Conduct of the research (A76-3) Tick all participants from NHS
29 Ethics: Common Reasons for Provisional Approvals (1) IRAS REC form Spelling mistakes and typos Anonymized tissue samples and data sets should be used whenever possible Unless, Confidentiality Advisory Group (CAG, formerly NIGB) Discrepancies between application form and protocol and patient/participant information sheets (PIS) Patient information sheet Too much technical information Insensitive or inappropriate language Clear procedures i.e. what is part of routine clinical care, what is additional for research Diagram of what will happen to participant Follow-ups should be clearly described Use visual terms, e.g. 10ml blood = 2 teaspoons State in PIS that the participant is free to withdraw at any time Separate information sheets for control groups/healthy volunteers/minors
30 Ethics: Common Reasons for Provisional Approvals (2) Consent forms Specific consent for genetic research Consent to use samples for any future research that may take place, emphasizing that full ethical approval will be sought for each future project Clarify what the patient must consent to in order to take part in the study, and what is optional Ask permission to inform the GP of their taking part in the study State that responsible individuals from regulatory authorities may look at sections of their medical notes
31 Amendments Substantial An amendment to the protocol or any other supporting documentation that is likely to affect to a significant degree the: 1. Safety or physical or mental integrity of the trial subjects 2. Scientific value of the trial 3. Conduct or management of the trial Non-substantial Requires notification only (e.g. typos, amending members of research teams except CI & PIs) Amendment forms generated in IRAS Inform Sponsor and Trust R&D REC has 35 days to respond Trust R&D must also approve
32 Progress Reports, Declaration of End of Study and Final Report Annual progress reports to REC Anniversary of REC approval Until end of study Declaration of End of Study to REC Appropriate form within 90 days of the end of the study Or within 15 days if the study is terminated early Final report on the research to REC Within 12 months of the end of the study No standard format required (but JREO can provide template) Copy all reports to the Sponsor and all R&D departments involved in the study
33 Other Approvals Confidentiality Advisory Group ( CAG formerly NIGB) - identifiable patient data Human Fertilisation & Embryology Authority (HFEA) - Creation of embryos in vitro and/or storing embryos Administration of Radioactive Substances Advisory Committee (ARSAC) Confirmation of compliance with Ionising Radiation (Medical Exposure) Regulations (IR(ME)R) Medicines and Healthcare products Regulatory Agency (MHRA) Medical Device R&D approvals - No study should commence without NHS Trust R&D approval
34 HRA Update
35 Useful Information o HRA o SGUL SOPs - governance/training/1an-overview-of-st-georges-sops-2013.pdf/view OR ohttps:// o Declaration of Helsinki - o European Convention of Human Rights and Biomedicine o World Health Organisation - o R&D Forum o IRAS researchgovernance@sgul.ac.uk
36 JREO Workshops * Talk will last approximately 1 hour* How to apply for ethics (CTIMPS) including Sponsorship 25 November 2015 Board Room H2.6 Hunter Wing 12:30 Research Contracts and Agreements 15 December 2015 G :30 How to apply for NHS R&D/Host site Approval 27 January 2016 Board Room H2.7 Hunter Wing 12:30 **For full list, please visit the portal or Trust website**
STANDARD OPERATING PROCEDURE FOR RESEARCH. 14. Amendments to Research Studies
Basildon and Thurrock University Hospitals NHS FT Research & Development APPROVED STANDARD OPERATING PROCEDURE FOR RESEARCH 1. BACKGROUND 14. Amendments to Research Studies Amendments are changes made
More informationHRA/Ethics Approval for Health-Related Research
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationSTP Project Ethical Approval Process
STP Project Ethical Approval Process Introduction This document has been produced specifically for STP trainees who will undertake their University of Manchester Masters research project within the NHS.
More informationEthical Approval. Document Number: 012
Ethical Approval Document Number: 012 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual: Liba Stones, Manager
More informationQUEEN S UNIVERSITY BELFAST. Regulations for Research Involving Human Participants
QUEEN S UNIVERSITY BELFAST Regulations for Research Involving Human Participants 1. Introduction Research involving human participants falls into a different category from other research carried out within
More informationAPPLICATION FORM. Application for a Recognised Research Ethics Committee (REC) Opinion on a Clinical Trial on a Medicinal Product for Human Use.
APPLICATION FORM Application for a Recognised Research Ethics Committee (REC) Opinion on a Clinical Trial on a Medicinal Product for Human Use. Form 1 This application form should be completed and submitted
More informationResearch Study Amendments
REFERENCE: VERSION NUMBER: 3.2 EFFECTIVE DATE: 05-02-18 REVIEW DATE: 05-02-20 AUTHOR: Clinical Trials Manager; Clinical Trials Officer REVIEWED BY: R&I Senior Team APPROVED BY: Deputy Director of Research
More informationLouise Brook Clinical Trials Quality Monitor. Date
Details: Author: Louise Brook Clinical Trials Quality Monitor SOP Pages: 12 Version No. of replaced SOP: Effective date of replaced SOP: NA NA Approval: Version No: of the SOP being approved. Name of person
More informationStandard Operating Procedure
Standard Operating Procedure Number: UM/UoM TMF/SOP08/6.0 Title: The Creation and Maintenance of Trial Master Files and Essential Documentation Version: 6.0 () Effective Date: Author: Mrs Catherine Barrow
More informationSTANDARD OPERATING PROCEDURE SOP 310
STANDARD OPERATING PROCEDURE SOP 310 DEVELOPMENT OF PARTICIPANT INFORMATION SHEET AND INFORMED CONSENT FORM Version 1.3 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 8 Review date April
More informationSOP14a: Standard Operating Procedure Applying for Ethical Approval
SOP14a: Standard Operating Procedure Applying for Ethical Approval Authorship Team: Jemma Hughes for Joint SOP Group on Trial Processes (viz Leanne Quinn, Ian Russell, Anne Seagrove, John Williams, Bridget
More informationThe Pathway of Project Approvals. Charlotte Davies- Research and Development Operations Manager
The Pathway of Project Approvals Charlotte Davies- Research and Development Operations Manager What do R&D do? Advises on relevant regulations and legislation Advises on planning and conduct of research
More informationResearch & Development. J Illingworth and S Moffat. Research, pharmacy and R&D staff
Department Title of SOP Research & Development SOP reference no: R&D GCP SOP 08 Authors: Reviewed by Current version number and date: J H Pacynko J Illingworth and S Moffat Version 4, 04.02.19 Next review
More informationRESEARCH AUDIT Standard Operating Procedure
Reference Number: UHB 236 Version Number: 2 Date of Next Review: 17 th Oct 2020 Previous Trust/LHB Reference Number: N/A RESEARCH AUDIT Standard Operating Procedure Introduction and Aim As a legal Sponsor
More informationResearch Governance Policy
Research Governance Policy Version: Status: Title of originator/author: Name of responsible director: Developed/revised by group/committee and Date: Approved by group/committee and Date: Effective date
More informationSTUDY DOCUMENTS. DOCUMENT NO.: CR007 v4.0. Marise Buçukoğlu ISSUE DATE: 07 MAR 2017 EFFECTIVE DATE: 21 MAR INTRODUCTION
STUDY DOCUMENTS DOCUMENT NO.: CR007 v4.0 AUTHOR: Marise Buçukoğlu ISSUE DATE: 07 MAR 2017 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research & Development (ACCORD) is a joint office
More informationConducting Clinical Trials of Investigational Medicinal Products
Title: Outcome Statement: Written By: Reviewed By: Conducting Clinical Trials of Investigational Medicinal Products Researchers in the Trust and research partners will be informed about the procedures
More informationPhase 1 studies and The Over- Volunteering Prevention System (TOPS)
Research Department STANDARD OPERATING PROCEDURE Phase 1 studies and The Over- Volunteering Prevention System () SOP Number C129 Version Number 1.0 Date effective 18 June 2018 Author Luke Barron Related
More informationWriting a Protocol for CTIMPs
REFERENCE: VERSION NUMBER: 4.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: REVIEWED BY: APPROVED BY: CONTROLLER: Clinical Trials Manager; Clinical Trials Officer Research & Innovation Group
More informationInvestigator Site File Index (Medical Devices)
Study Title: Site Name/Number: REC Reference Number: Sponsor Reference Number: EudraCT Number: 1. Protocol (Clinical Investigation Plan) Current version plus all previous versions (or provide file note
More informationTrial Committees SOP Number: 47 Version Number: 2.0 Effective Date: 01/02/2017 Review Date: 01/02/2019
Standard Operating Procedures (SOP) for: Trial Committees SOP Number: 47 Version Number: 2.0 Effective Date: 01/02/2017 Review Date: 01/02/2019 Author: Reviewer: Reviewer: Authorisation: Name / Position:
More informationJoint Research Office
Office Location: 1 st Floor Maple House 149 Tottenham Court Road London W1T 7DN Joint Research Office Tel: 020 3447 5557 Fax: 020 3447 9937 Website: www.uclh.nhs.uk; www.ucl.ac.uk; www.ucl.ac.uk/jro Postal
More informationResearch Governance Policy and Procedure
Research Governance Policy and Procedure Version: 5 Name of originator/author: Name of executive lead: Date ratified: Review date: APPLICABLE TO: All staff. EXECUTIVE SUMMARY Dr Lisa Austin- University
More informationApplication form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE
Application form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE In completing this form please refer to the attached Notes of Guidance Application for approval of all studies involving Healthy
More informationRDSOP16 Writing a GCP Compliant Protocol for Non-CTIMPs. Greater Manchester Mental Health NHS Foundation Trust
RDSOP16 Writing a GCP Compliant Protocol for Non-CTIMPs Greater Manchester Mental Health NHS Foundation Trust Title of Standard Operating Procedure: RDSOP16 Writing a GCP Compliant Protocol for Non-CTIMPs
More informationStudy Files and Filing
Study Files and Filing The current version of all Hillingdon Hospital R&D Guidance Documents and Standard Operating Procedures are available from the R&D Intranet and Internet sites: www.ths.nhs.uk/departments/research/research.htm
More informationSTANDARD OPERATING PROCEDURE SOP 320. Developing a Research Protocol
STANDARD OPERATING PROCEDURE SOP 320 Developing a Research Protocol Version 2.1 Version date 26.03.2017 Effective date 26.03.2017 Number of pages 14 Review date April 2019 Author NNUH UEA Joint Research
More informationInvestigator Site File Index (CTIMP)
Study Title: Site Name/Number: REC Reference Number: Sponsor Reference Number: EudraCT Number: 1. Protocol Current version plus all previous versions (or provide file note to detail location of previous
More informationTrial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products
1 Trial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products SECTION TITLE DOCUMENTS 1. Contact List Including details of relevant study site staff, responsible
More informationOnce notified of the end of trial, a Research Manager, on behalf of the Sponsor, will contact the CI to arrange a close down monitoring visit.
1. INTRODUCTION This SOP has been produced in accordance with the requirements of The Medicines for Human Use (Clinical Trials) Regulations 2004, Medicines for Human Use (Clinical Trials) Amendment Regulations
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Essential Documentation and Creation and Maintenance of Trial Master File SOP Number: 13 Version Number: 2.0 Supercedes:
More informationSally Burtles, Director of Research Services & Business Development
Standard Operating Procedures (SOP) for: Process for Researchers - Amendments for Sponsored Studies (including halting studies and early termination) SOP Number: 17c Version Number: 2.0 Effective Date:
More informationR&D Administration Manager. Research and Development. Research and Development. NHS Staff Trust-Wide THIS IS A CONTROLLED DOCUMENT
Document Title: Document Number: Research Protocol Design for Papworth Sponsored Studies SOP019 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by:
More informationESSENTIAL DOCUMENTS DURING THE CLINICAL CONDUCT OF THE TRIAL
ESSENTIAL DOCUMENTS DURING THE CLINICAL CONDUCT OF THE TRIAL THIS INFORMATION SHEET (ISR-RG-014) HAS BEEN TAKEN DIRECTLY FROM THE ICH- GUIDELINE* WITH ADDITIONAL COMMENTS ADDED BY THE RESEARCH GOVERNANCE
More informationShort Introduction. Main Introduction. The Basics
Short Introduction Set-up and delivery of a clinical research project can be complicated and difficult. We introduce the regulatory processes involved in gaining approval for clinical research and discuss
More informationSetting up new studies where NBT are sponsor
Setting up new studies where NBT are sponsor Task Why Task Should Happen When Task Should Happen Who Should Complete Task How Task is Completed TASK 1: Apply for confirmation that NBT can sponsor the study
More informationStandard Operating Procedure: Obtaining Informed Consent from Competent Adults for Research Studies. SOP Number: UoA-NHSG-SOP-010 Version No: 2
Standard Operating Procedure: Obtaining Informed Consent from Competent Adults for Research Studies SOP Number: UoA-NHSG-SOP-010 Version No: 2 Author: Date: 27 th March 2015 (Carole Edwards, Lead Research
More informationSponsorship of Clinical Research Studies
Sponsorship of Clinical Research Studies Category: Summary: Equality Impact Assessment undertaken: Policy The UK Policy Framework for Health and Social Care 2017 (UKPF) and The Medicines for Human Use
More informationCombined trial of an investigational medicinal product and an investigational medical device
Welcome to the Integrated Research Application System IRAS Project Filter The integrated dataset required for your project will be created from the answers you give to the following questions. The system
More informationRD SOP32 Gaining MHRA Approval
RD SOP32 Gaining MHRA Approval Version Number: 1.0 Name of originator/author: Dr Lloyd Gregory Name of responsible committee: R&I Committee Name of executive lead: Medical Director & Director of Quality
More informationScotland A REC 2 nd Floor Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG
Scotland A REC 2 nd Floor Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG Telephone: 0131-465-5679 19 February 2016 Professor Karim Brohi Professor of Trauma Science Queen Mary University of London
More informationStandard Operating Procedure Research Governance
Research and Enterprise Standard Operating Procedure Research Governance Title: Development, Review and Amendment: Study Protocol SOP Reference Number: QUB-ADRE-002 Date prepared 28 May 2008 Version Number:
More informationStandard Operating Procedure: Obtaining Informed Consent from Competent Adults for Research Studies. SOP Number: SOP-QA-9 Version No: 1
Standard Operating Procedure: Obtaining Informed Consent from Competent Adults for Research Studies SOP Number: SOP-QA-9 Version No: 1 Author: Date: 1-9-15 (Carole Edwards, Lead Research Nurse, NHS Grampian)
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number End of Study Notification and Premature Discontinuation of a Study SOP-RES-025 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016
More informationSTANDARD OPERATING PROCEDURE FOR RESEARCH. 17. Study Close Down
Basildon and Thurrock University Hospitals NHS FT Research & Development APPROVED STANDARD OPERATING PROCEDURE FOR RESEARCH 1. BACKGROUND 17. Study Close Down According to ICH Good Clinical Practice (GCP)
More informationEnd of Study Notification, Close-Out and Reporting Sponsored Research. Noclor/Spon/S11/01. SOP Reference ID:
End of Study Notification, Close-Out and Sponsored Research SOP Reference ID: Noclor/Spon/S11/01 Version Number 1.0 Effective Date: 6 th June 2016 It is the responsibility of all users of this SOP to ensure
More informationRESEARCH IN HUMAN SUBJECTS OTHER THAN CLINICAL TRIALS OF INVESTIGATIONAL MEDICINAL PRODUCTS
Page 1 of 5 RESEARCH IN HUMAN SUBJECTS OTHER THAN CLINICAL TRIALS OF INVESTIGATIONAL MEDICINAL PRODUCTS After ethical review guidance for sponsors and investigators This document sets out important guidance
More informationInspections: an academic perspective
Inspections: an academic perspective Patricia Henley Quality and Governance Manager Head, Research Governance & Integrity Office London School of Hygiene & Tropical Medicine Email: patricia.henley@lshtm.ac.uk
More informationNHS Research Ethics Approval the process
NHS Research Ethics Approval the process Dr Sheila A Simpson 27 May 2008 ETHICS The process of determining what is right and wrong Personal code of conduct based on respect for one's self, others, and
More informationNHS REC Applications
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationRESEARCH SUPPORT SERVICES FRAMEWORK. Streamlining the management and governance of R&D studies in the NHS
RESEARCH SUPPORT SERVICES FRAMEWORK Streamlining the management and governance of R&D studies in the NHS Page 1 of 22 Contents 1. INTRODUCTION... 3 How to use this document... 3 Background... 4 Purpose
More informationNRES Committee East of England - Cambridge Central Royal Standard Place Nottingham NG1 6FS
22 April 2015 NRES Committee East of England - Cambridge Central Royal Standard Place Nottingham NG1 6FS Professor Willem Ouwehand Wellcome Trust Sanger Institute, Honorary NHSBT Consultant in Haematology.
More informationCode break is also known as breaking the blind and involves un-blinding a participant so that the treatment allocation is made known.
1. INTRODUCTION This SOP has been produced in accordance with Medicines for Human Use (Clinical Trials) Regulations 2004. This SOP will outline the procedure for breaking the study code in a NUH sponsored
More informationMarie-Claire Good, RG and GCP Manager James Rickard, Deputy Chief Pharmacist Technical Services Cheryl Lawrence, Senior Research Pharmacist
Standard Operating Procedures (SOP) for: IMP Management BH/QMUL Sponsored CTIMPs SOP Number: 42a Version Number: 3.0 Effective Date: 14 th August 2017 Review Date: 14 th August 2019 Author: Reviewer: Reviewer:
More informationResearch Study Close-down and Archiving Procedures
Title: Research Study Close-down and Archiving Procedures Outcome Statement: To inform researchers of the process for closing down research studies, retaining and storing research materials in the Trust.
More informationThe EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Ireland
The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Ireland Question 1: What laws or regulations apply to an application for conducting a clinical
More informationPERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES
PERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES Version Control Item 19 Items 25, 26 Item 29 Update to the Publication requirements Update of Submission Timetable
More informationStandard Operating Procedure. Vendor Management
REFERENCE: VERSION NUMBER: 2.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Clinical Trials Manager, Contracts & Quality Management Officer REVIEWED BY: Research & Innovation Group APPROVED BY:
More informationAPPLICANT'S CHECKLIST
APPLICANT'S CHECKLIST Research tissue bank (or other research biobank) REC Ref: Title of Tissue Bank: Applicant's Name: Name of Designated Individual: Please complete this checklist and send it with your
More informationETHICS, IRAS & DATA PROTECTION
ETHICS, IRAS & DATA PROTECTION Clinical Research Methods Course 14 th March 2017 Priyanthi Dias Senior Trials Coordinator Adult CriDcal Care Research Unit Queen Mary University of London p.dias@qmul.ac.uk
More informationStandard Operating Procedure (SOP) for the Development, Management & Control of Research-Related SOPs
Standard Operating Procedure (SOP) for the Development, Management & Control of Research-Related SOPs For Completion by SOP Author Reference Number Version Document Author(s) Document Reviewer(s) PHT/RDSOP/001
More informationConfirming Research Study Capacity and Capability
Title: Outcome Statement: Written By: Confirming Research Study Capacity and Capability Researchers will be informed about the procedures and requirements for obtaining permission to conduct a research
More informationIMP Management and Accountability
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationUsing Human Tissue in Translational Research and Clinical Trials
Using Human Tissue in Translational Research and Clinical Trials Dr Bridget S Wilkins NCRI Clinical Lead for Pathology Engagement (Consultant Histopathologist, St Thomas Hospital, London) Cellular and
More informationA step by step guide to using IRAS to apply to conduct research in or through the NHS/HSC.
A step by step guide to using IRAS to apply to conduct research in or through the NHS/HSC. 28 June 2017 Summary All project-based research conducted in or through the NHS/HSC in England, Northern Ireland,
More informationHouse of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data
House of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data Evidence submitted by the Medical Research Council, 26 February 2013 Introduction 1. The Medical Research
More informationTrial oversight SOP for HEY-sponsored CTIMPs
R&D Department Trial oversight SOP for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored in a retrieval system
More informationR&D Administration Manager. Research and Development. Research and Development
Document Title: Document Number: Trial Closure and End of Trial SOP021 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D Administration
More informationWriting a Protocol to Good Clinical Practice (GCP)
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationIndex of Standard Operating Procedures for all research Sponsored by the UHL
University Hospitals of Leicester NHS Trust () Index of Standard Operating Procedures for all research Sponsored by the March Please note that with effect from 2015, all SOPs and Appendices use the same
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Non Compliance and Serious Breach Reporting SOP-RES-017 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov
More informationMRC. Clinical Trials. Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS. Medical Research Council
MRC Clinical Trials Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 Medical Research Council MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 MRC GUIDELINES FOR
More informationLow/Negligible Risk Research Ethics and Governance Application Guidelines
Low/Negligible Risk Research Ethics and Governance Application Guidelines A human research project cannot commence at a site within Central Adelaide Local Health Network (including Royal Adelaide Hospital
More informationGeorge E. Griffin PhD, FRCP, F Med Sci Professor of Medicine and Infectious Diseases. Amsterdam, Jan. 2010
Good Clinical Practice Guidelines and the European Directive. How Can Investigator-initiated Research Survive? Current UK Situation-Academic Perspective. George E. Griffin PhD, FRCP, F Med Sci Professor
More informationSTANDARD OPERATING PROCEDURE SOP 410. Set up and Initiation of an Investigator Site
STANDARD OPERATING PROCEDURE SOP 410 Set up and Initiation of an Investigator Site Version 1.2 Version date 4.01.2017 Effective date 5.07.2017 Number of pages 13 Review date July 2019 Author Role NNUH
More informationDate: 21 st May 2014 Version: 5 Page 1 of 11. Principal Author Name D. Skelhorn Signature: D. Skelhorn Date: 22 nd May 2014
Date: 21 st May 2014 Version: 5 Page 1 of 11 STANDARD OPERATING PROCEDURE FOR MONITORING CLINICAL TRIALS (NWORTH 3.07) Approvals Principal Author Name D. Skelhorn Signature: D. Skelhorn Date: 22 nd May
More informationThe role of the Clinical Trials Unit Emma Hall PhD CStat Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU)
in partnership with The role of the Clinical Trials Unit Emma Hall PhD CStat Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU) CTRad Clinical Trials Workshop 14/10/2014 What is
More informationTrial Master File. SOP No. SOP 7
Trial Master File SOP Title Trial Master File SOP No. SOP 7 Author Consultation Departments Date approved Julia Farmery Lincolnshire Clinical Research Facility, Research and Development, Trust consultants
More informationPrimary Care mcta 2013: Guidance for use
GUIDANCE ON USE OF THE MODEL CLINICAL TRIAL AGREEMENT FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY SPONSORED RESEARCH IN PRIMARY CARE (PRIMARY CARE mcta, 2013 VERSION) Background to the development
More informationPublic Consultation Paper: Assessment of the Functioning of the Clinical Trials Directive 2001/20/EC
Public Consultation Paper: Assessment of the Functioning of the Clinical Trials Directive 2001/20/EC National Institute for Health Research (NIHR CRN) and UKCRC Registered Clinical Trials Units Response
More informationDevelopment Safety Update Report Guidance
Development Safety Update Report Guidance This document provides instructions for the preparation and submission of a Development Safety Update Report (DSUR) for a Clinical Trial of an Investigational
More informationControlled Document Number: Version Number: 2 Controlled Document Sponsor: Controlled Document Lead:
University Hospitals Birmingham Policy on Human Tissue in Research NHS Foundation Trust CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 2 Controlled Document
More informationUK COMPATIBILITY HEALTH RESEARCH AUTHORITY APPROVAL WHAT IS HEALTH RESEARCH AUTHORITY APPROVAL?
UK COMPATIBILITY HEALTH RESEARCH AUTHORITY APPROVAL WHAT IS HEALTH RESEARCH AUTHORITY APPROVAL? Health Research Authority (HRA) Approval is a new process for the NHS in England that assesses a research
More informationComparison of admission rates to neonatal units between PO screening and non-po screening Units
London - Westminster Research Ethics Committee 4 Minshull Street Manchester M1 3DZ Telephone: 0207 104 8012 Please note: This is the favourable opinion of the REC only and does not allow you to start your
More informationMRC Additional Terms and Conditions
MRC Additional Terms and Conditions The MRC additional terms and conditions of funding supplement those of RCUK. These conditions set out operational, legislative and ethical requirements relating to medical
More informationDocument Title: Annual Progress Reports (APRs) Document Number: 056
Document Title: Annual Progress Reports (APRs) Document Number: 056 Version: 1 Ratified by: Committee Date ratified: 30/11/2017 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationHealth Research Authority (HRA) What do you need to know?
Health Research Authority (HRA) What do you need to know? Background why another change? Cohorts Cohort Type of Study Live date 1 Health services research not requiring REC review 11 th May 2015 2 Studies
More informationIndex of Standard Operating Procedures for all research Sponsored by the UHL
University Hospitals of Leicester NHS Trust () Index of Standard Operating Procedures for all research Sponsored by the October Please note that with effect from 2015, all SOPs and Appendices use the same
More informationInvestigational Medicinal Product (IMP) Management Standard Operating Procedure
Reference Number: UHB 040 Version Number: 3 Date of Next Review: 26 Apr 2019 Previous Trust/LHB Reference Number: T 363 Standard Operating Procedure Introduction and Aim This procedure is written to support
More informationPERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIAL FEEDBACK PROCESS HRA APPROVED TRIALS
PERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIAL FEEDBACK PROCESS HRA APPROVED TRIALS Version Control New document 1 Acronyms CTP DSC DSS FPR HRA MHRA REC SOP Clinical Trial Performance
More informationHRA Approval in Primary Care Settings Principles of Study Set-Up
HRA Approval in Primary Care Settings: Principles of Study Set-Up Document Title: HRA Approval in Primary Care Settings Principles of Study Set-Up Version Number: 2.0 Issue Date: 09 March 2017 Author:
More informationOHRN Toolkit. Edited by Adrian Hayes, Charlotte Lennox and Jane Senior. January 2010, Fourth Edition
OHRN Toolkit Edited by Adrian Hayes, Charlotte Lennox and Jane Senior January 2010, Fourth Edition Copyright The Offender Health Research Network Title: Researchers Handbook: A Guide for Researchers in
More informationDocument Title: Site Recruitment and Initiation for Papworth Sponsored Studies
Document Title: Site Recruitment and Initiation for Papworth Sponsored Studies Document Number: SOP015 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For
More informationSTUDY CLOSURE AND ARCHIVING
STUDY CLOSURE AND ARCHIVING DOCUMENT NO.: CR009 v2.0 AUTHOR: Lynn Smith ISSUE DATE: 15 August 2016 EFFECTIVE DATE: 29 August 2016 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research
More informationIndustry pack Guidance for the set-up of hosted clinical trials
Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London Industry pack Guidance for the set-up of hosted clinical trials Contents Section 1 Introduction
More informationClinical Trials application process, legislation & guidelines
Clinical Trials application process, legislation & guidelines IMB Clinical Trials Seminar 19 th June 2012 Elaine Breslin MB BCh (NUI), PhD, FRCPI Clinical Assessment Manager 19/06/2012 Slide 1 IMB Mission
More informationGOOD CLINICAL PRACTICE TRAINING POLICY FOR PERSONNEL UNDERTAKING RESEARCH. UHB015 Version No: 2 Previous Trust / LHB Ref No:
GOOD CLINICAL PRACTICE TRAINING POLICY FOR PERSONNEL UNDERTAKING RESEARCH Reference No: UHB015 Version No: 2 Previous Trust / LHB Ref No: N/A Documents to read alongside this Policy, Procedure etc (delete
More informationBRAIN UK UK Brain Archive Information Network
BRAIN UK UK Brain Archive Information Network TISSUE REQUEST FORM Version 1.4 Date: 11 February 2011-1 - Ref: 11/SC/0056 GUIDANCE NOTES Please complete all sections of this form and send an electronic
More informationRESEARCH AND INNOVATION (R&I) Research Capacity and Capability Assessment Guidance
RESEARCH AND INNOVATION (R&I) Research Capacity and Capability Assessment Guidance Title: Prepared for: Author: Purpose of document: Research Capacity, Capability and Delivery Guidance Research & Innovation
More informationUNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH SUPPORT OFFICE
UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH SUPPORT OFFICE STANDARD OPERATING PROCEDURES University of Leicester (UoL) Research Governance
More information